| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/11/1998 | WO1998039464A2 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 09/11/1998 | WO1998039441A1 Human chemokine receptor-like chemokine |
| 09/11/1998 | WO1998039435A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
| 09/11/1998 | WO1998039434A1 Methods and reagents for modulating apoptosis |
| 09/11/1998 | WO1998039433A1 Complement receptor type 1 (cr1)-like sequences |
| 09/11/1998 | WO1998039429A2 Compositions for treatment of disorders involving programmed cell death |
| 09/11/1998 | WO1998039332A1 2-aryl-naphthyridin-4-ones as antitumor agents |
| 09/11/1998 | WO1998039329A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/11/1998 | WO1998039327A1 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
| 09/11/1998 | WO1998039323A1 Anti-mitotic agents which inhibit tubulin polymerization |
| 09/11/1998 | WO1998039311A1 Antibacterial heterocyclic amino acid derivatives |
| 09/11/1998 | WO1998039303A1 Small molecules useful in the treatment of inflammatory disease |
| 09/11/1998 | WO1998039299A1 5-oxysubstituted chinolines and their use as cholesterol ester transfer proteins inhibitors |
| 09/11/1998 | WO1998039280A1 Phenylpropenone compounds and medicines containing the same |
| 09/11/1998 | WO1998039037A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 09/11/1998 | WO1998039028A1 Lyme combination compositions and uses |
| 09/11/1998 | WO1998039024A1 Selective mmp inhibitors having reduced side-effects |
| 09/11/1998 | WO1998039006A1 Troglitazone compounds for treating climacteric |
| 09/11/1998 | WO1998038995A1 Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent |
| 09/11/1998 | WO1998038986A2 Use of carvedilol or derivatives thereof for the manufacture of a medicament for the prevention and treatment of viral infections |
| 09/11/1998 | WO1998038859A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | WO1998030584A3 Secreted proteins and polynucleotides encoding them |
| 09/11/1998 | WO1998025956A3 Human GTP-binding proteins |
| 09/11/1998 | WO1998023243A3 Pharmaceutical, cosmetic composition with base of microbial culture mixed with an essential oil and an acid |
| 09/11/1998 | CA2285405A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/11/1998 | CA2283791A1 Troglitazone compounds for treating climacteric |
| 09/11/1998 | CA2283471A1 Anti-mitotic agents which inhibit tubulin polymerization |
| 09/11/1998 | CA2283275A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | CA2283272A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 09/11/1998 | CA2283257A1 Phenylpropenone compounds and medicines containing the same |
| 09/11/1998 | CA2283145A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 09/11/1998 | CA2282851A1 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
| 09/11/1998 | CA2282760A1 Human chemokine receptor-like chemokine |
| 09/11/1998 | CA2282691A1 Antibacterial heterocyclic amino acid derivatives |
| 09/11/1998 | CA2282399A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 09/11/1998 | CA2282318A1 N-hydroxy 4-sulfonyl butanamide compounds |
| 09/11/1998 | CA2281484A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
| 09/11/1998 | CA2280134A1 Selective mmp inhibitors having reduced side-effects |
| 09/11/1998 | CA2278547A1 Small molecules useful in the treatment of inflammatory disease |
| 09/10/1998 | DE19711503C1 Pharmazeutische Zusammensetzung zur Aufhebung der membranvermittelten Resistenz von Zellen A pharmaceutical composition for the abolition of membrane-mediated resistance of cells |
| 09/10/1998 | DE19709125A1 Substituierte Chinoline Substituted quinolines |
| 09/10/1998 | CA2231591A1 Bovine respiratory coronavirus |
| 09/09/1998 | EP0863208A2 Histidine Kinase polypeptides, polynucleotides encluding the same and use thereof |
| 09/09/1998 | EP0863207A1 RNA dependent amidotransferase A from Staphylococcus Aureus |
| 09/09/1998 | EP0863143A1 Intermediates useful in the production of pyridopyrimidone angiotensin AII antagonists |
| 09/09/1998 | EP0863139A1 Benzoxazindione derivatives, process for their preparation and their use |
| 09/09/1998 | EP0862910A2 Use of retinoids as skin pigmentation inducing agent |
| 09/09/1998 | EP0862644A2 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders |
| 09/09/1998 | EP0862628A1 Receptor and nucleic acid molecule encoding said receptor |
| 09/09/1998 | EP0862574A1 Metal complexes as cysteine protease inhibitors |
| 09/09/1998 | EP0862567A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 09/09/1998 | EP0862566A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 09/09/1998 | EP0862565A1 Tricyclic spiro compounds as 5ht 1d? receptor antagonists |
| 09/09/1998 | EP0862559A1 Novel fluorinated or hydroxylated phenylimidazolidines having anti-androgenic activity, method for preparing same, resulting intermediates, and pharmaceutical compositions |
| 09/09/1998 | EP0862557A1 SYMMETRICAL bis-HETEROARYLMETHOXYPHENYLALKYL CARBOXYLATES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS |
| 09/09/1998 | EP0862555A1 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 09/09/1998 | EP0862554A1 Aromatic carboxylic acid esters, the production of same and use of same as medicaments |
| 09/09/1998 | EP0862552A1 Succinimide and maleimide cytokine inhibitors |
| 09/09/1998 | EP0862460A1 Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling |
| 09/09/1998 | EP0862452A1 Stabilizing formulation for ngf |
| 09/09/1998 | EP0862435A1 Inhibitors of farnesyl-protein transferase |
| 09/09/1998 | EP0862432A1 Two-photon upconverting dyes and applications |
| 09/09/1998 | EP0862429A1 Method of adjusting the circadian rhythm of a mammal |
| 09/09/1998 | EP0862428A1 Ginkgolides for inhibition of membrane expression |
| 09/09/1998 | EP0716649B1 5-arylindole derivatives |
| 09/09/1998 | EP0715627B1 Indole derivatives as thromboxane a2 antagonists |
| 09/09/1998 | EP0691966B1 Quinolines as type iv phosphodiesterase inhibitors |
| 09/09/1998 | EP0651641B1 Novel bioactive compositions, preparation and use thereof |
| 09/09/1998 | EP0617620B1 Use of 5-ht4 - antagonists for the manufacture of a medicament for the treatment of urinary incontinence |
| 09/09/1998 | EP0591280B1 Use of tetrahydrocarbazole derivatives as 5ht1-receptor agonists |
| 09/09/1998 | CN1192751A Monocype chemotactic protein-4 |
| 09/09/1998 | CN1192747A Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| 09/09/1998 | CN1192740A Novel camptothecin analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same |
| 09/09/1998 | CN1192739A N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 09/09/1998 | CN1192732A CB2 receptor agonist compounds |
| 09/09/1998 | CN1192729A Benzamide derivatives and their use as vasopressin antagonists |
| 09/09/1998 | CN1192697A Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 09/09/1998 | CN1192696A Spironolactone and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 09/09/1998 | CN1192685A Use of alendronate for preventing osteoporosis |
| 09/09/1998 | CN1192679A Compounds active at a novel side on receptor-operated calcium channel useful for treatment of neurological disorders |
| 09/09/1998 | CN1192436A New-benzylpiperazine compounds, process for their prepn. and pharmaceutical compositions which contain them |
| 09/09/1998 | CN1039714C Substituted indole derivatives, prepn. method and application thereof |
| 09/08/1998 | US5804686 fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
| 09/08/1998 | US5804599 Oxabicyclo(4.1.0)heptane derivatives; antibacterial agents |
| 09/08/1998 | US5804596 Administration; preferential incorporation of nutrients to lean body mass, not adipose tissue |
| 09/08/1998 | US5804593 For treatment of connective tissue degradation, osteo-, rheumatoid-, and septic arthritis; osteopenias, osteoporosis, corneal ulceration, peridontal disease, gastric ulcers. |
| 09/08/1998 | US5804588 Quinoline carboxanides and their therapeutic use |
| 09/08/1998 | US5804571 Administering an s-omega(omega-aminoalkylamino)alkyl dihydrogen phosphorothioate |
| 09/08/1998 | US5804570 Administering 4-amino-1-hydroxy-butylidene-1,1-bisphosphonate (alendronate) or salt to osteoporotic female |
| 09/08/1998 | US5804566 Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
| 09/08/1998 | US5804559 Prodrug derivatives of enzyme inhibitors having hydroxyl groups, a process for preparing them, and their use |
| 09/08/1998 | US5804555 Lactoferrin hydrolyzate mixed with oxidation preventing agent(s); food and drug safe |
| 09/08/1998 | US5804554 Calcium channel blocking polypeptides from filistata hibernalis |
| 09/08/1998 | US5804551 Stroma-free modified hemoglobin; improving recovery |
| 09/08/1998 | US5804550 Peptide antagonists at glutamate and NMDA receptors |
| 09/08/1998 | US5804419 Encoded by a polynucleotide sequence; forming hybridization complex with nucleic acid material of sample; detecting complex. |
| 09/08/1998 | US5804399 Incubation; measuring effect of composition on kinase or polynucleotide encoding the kinase |
| 09/08/1998 | US5804204 Potassium salts for treatment of hypertension |
| 09/08/1998 | US5804190 Recombinant vaccine for porcine pleuropneumonia |
| 09/08/1998 | US5804176 Compositions comprising leukocyte-derived growth factors and methods of administering same to facilitate wound healing |